Personal Cfo Solutions, LLC Iveric Bio, Inc. Transaction History

Personal Cfo Solutions, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$9.12 - $18.9 $98,495 - $204,119	-10,800 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$12.15 - $16.83 $6,075 - $8,415	-500 Reduced 4.42%	10,800 $182,000
Q3 2021 Nov 18, 2021	SELL	$7.07 - $17.5 $4,949 - $12,250	-700 Reduced 5.83%	11,300 $184,000
Q3 2020 Nov 02, 2020	BUY	$4.01 - $6.29 $2,005 - $3,145	500 Added 4.35%	12,000 $0
Q2 2020 Aug 03, 2020	BUY	$3.06 - $6.6 $35,190 - $75,900	11,500 New	11,500 $59,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Personal Cfo Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Personal Cfo Solutions, LLC with notifications on news.